High Court Nixes Pfizer's Bid For Quick Review
The nation's highest court has rejected Pfizer Inc.'s request to expedite its bid for a writ of certiorari in a patent feud with Apotex Inc. over blockbuster blood pressure drug Norvasc....To view the full article, register now.
Already a subscriber? Click here to view full article